Sanofi and Regeneron share pop, data shows asthma drug Dupixent could treat COPD
A logo on the Sanofi exhibition space during the Viva Technology conference dedicated to innovation and startups at the Porte de Versailles exhibition center in Paris, France on June 15, 2022. Benoit Tessier | Reuters Shares of Sanofi And Regenerate both jumped more than 6% on Thursday after pharmaceutical companies released promising data showing that …
Sanofi and Regeneron share pop, data shows asthma drug Dupixent could treat COPD Read More »